Xeris Biopharma Holdings, Inc. - Common Stock — Cash Flow (NASDAQ:XERS) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -95.53 M-102.89 M-47.02 M-36.98 M28.63 M 48.53 M Cash from investing activities 97.96 M34.46 M-6 M4.88 M-696 K -1.01 M Cash from financing activities 27.25 M127.47 M-1.61 M36.17 M11.39 M 5.69 M Free cash flow -95.53 M-102.89 M-47.02 M-36.98 M28.63 M 48.53 M

News

Xeris Biopharma (XERS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Xeris Pharmaceuticals at Barclays: Strong Growth Fueled by RECORLEV

Xeris Biopharma Holdings, Inc. (XERS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Xeris Biopharma (XERS) Reports Q4 Earnings: What Key Metrics Have to Say

Xeris Biopharma (XERS) Q4 Earnings and Revenues Surpass Estimates

Xeris Biopharma stock up nearly 3% after Q4 EPS beat, above estimate guidance

Xeris Pharmaceuticals earnings beat by $0.04, revenue topped estimates

Xeris Pharmaceuticals faces earnings test as growth accelerates

Why Are Shares Of Xeris Biopharma Falling Friday? - Xeris Biopharma Holdings (NASDAQ:XERS)

BioCryst Pharmaceuticals (BCRX) Q4 Earnings and Revenues Surpass Estimates

Unlocking Q4 Potential of Xeris Biopharma (XERS): Exploring Wall Street Estimates for Key Metrics

Xeris Biopharma director Shannon sells $176k in shares